Retatrutide vs Tirzepatide: How the Next-Gen GLP Compares to Zepbound

The Quick Answer

If you're here for the short version: retatrutide produces more weight loss than tirzepatide in clinical trials, but it's not FDA approved yet and has a slightly rougher side effect profile. Tirzepatide (sold as Zepbound for weight loss and Mounjaro for diabetes) is available right now and has an excellent track record. Retatrutide is likely 1-2 years away from approval.

How They Work: Triple vs Dual Agonist

Both medications are made by Eli Lilly. Tirzepatide targets two hormone receptors: GLP-1 and GIP. These are the same pathways that Ozempic (semaglutide) uses, except tirzepatide hits both instead of just GLP-1. The dual action is what makes tirzepatide more effective than semaglutide for weight loss -- a head-to-head trial called SURMOUNT-5 showed tirzepatide achieved 20.2% weight loss compared to 13.7% for semaglutide at 72 weeks.

Retatrutide takes it a step further by adding a third receptor: glucagon. This is significant because glucagon activation is thought to increase energy expenditure and boost fat oxidation -- essentially telling your body to burn more fat, not just eat less. The combination of appetite suppression (from GLP-1 and GIP) plus increased fat burning (from glucagon) is what researchers believe drives the higher weight loss numbers.

Weight Loss Results Compared

Here's where the data gets interesting. No head-to-head trial between retatrutide and tirzepatide has been conducted, so we're comparing results from separate trials with different populations. Keep that in mind -- these are cross-trial comparisons.

The headline number is clear: retatrutide produced about 6 percentage points more weight loss than tirzepatide at the highest doses. At the 12mg dose, participants on retatrutide lost an average of 71 pounds. That's nearly 20 pounds more than tirzepatide's 15mg dose.

Both medications had participants still losing weight at the end of the trial, meaning the full potential wasn't reached in either case. Longer trials could show even greater results for both.

Side Effects Compared

This is where tirzepatide has a clear advantage. Both medications share the typical GI side effects (nausea, diarrhea, constipation, vomiting), but retatrutide adds a couple of unique ones.

The dysesthesia is the standout difference. This skin sensitivity -- which I personally experienced as a constant sunburn-like sensation -- affected about 1 in 5 people on the highest retatrutide dose. It's believed to be caused by the glucagon receptor activation, which is the same mechanism driving the extra weight loss. More reward, more risk. I wrote about my full experience with this and every other side effect in my retatrutide side effects post.

The discontinuation rate is also notable: roughly 18% of people on the highest retatrutide dose stopped due to adverse events, compared to about 7% for tirzepatide. Though Eli Lilly noted that some retatrutide discontinuations were due to "perceived excessive weight loss" rather than side effects, which is an interesting nuance.

Availability and FDA Status

This is the biggest practical difference between the two right now.

Tirzepatide is FDA approved and available today. It's sold as Zepbound for weight management and Mounjaro for type 2 diabetes. You can get a prescription from your doctor. It was approved for obesity in November 2023.

Retatrutide is not FDA approved. It's currently in Phase 3 clinical trials through Eli Lilly's TRIUMPH program. The TRIUMPH-4 results (the osteoarthritis trial) were released in December 2025, and seven additional Phase 3 trials are expected to complete in 2026. If everything goes well, an FDA submission could happen in late 2026 with potential approval in 2027.

That means if you're looking for a GLP medication you can start today, tirzepatide is the clear choice. Retatrutide is not legally available outside of clinical trials, and the FDA has specifically warned about counterfeit retatrutide products being sold online.

Cost Comparison

Since retatrutide isn't approved yet, there's no official pricing. But we can look at tirzepatide as a reference point.

Zepbound (tirzepatide for weight loss) has a list price of roughly $1,000-1,100 per month in the US without insurance. With insurance coverage or manufacturer savings programs, the out-of-pocket cost can be significantly lower. Mounjaro (tirzepatide for diabetes) is similarly priced.

When retatrutide does reach the market, expect similar or potentially higher pricing given its additional mechanism and likely positioning as a premium option. Both medications are made by Eli Lilly, so pricing strategy will likely be coordinated.

My Personal Take (As Someone on Retatrutide)

I've been on retatrutide for 11 months total and lost 90 pounds. You can read the full month-by-month breakdown in my retatrutide before and after post. I haven't taken tirzepatide, so I can only compare my experience to the clinical data.

What I can say is this: retatrutide worked incredibly well for me. The appetite suppression was life-changing. But the side effects were real -- the skin sensitivity, the sleep disruption, the reduced sex drive. If tirzepatide could have gotten me to the same place with fewer side effects, would I have preferred it? Probably. But retatrutide got me from 280 to 190 in 6 months, which is a pace that tirzepatide's trial data suggests would be harder to match.

If I were advising someone today, here's how I'd think about it:

• If you can get tirzepatide (Zepbound) through your doctor: Start there. It's FDA approved, well-studied, effective, and has a better side effect profile. Losing 20%+ of your body weight is life-changing.
• If you've tried tirzepatide and plateaued or need more weight loss: Retatrutide may be worth watching for when it gets approved. The additional glucagon mechanism could provide the extra push.
• If you're considering either medication: Track your progress. Daily weigh-ins and progress photos are what kept me accountable and helped me correlate side effects with dose changes. I built WeightSnap specifically for this.

If you want 1-on-1 coaching from someone who's been through this journey, head to client.weightsnap.app and enter code LOSEIT.

Frequently Asked Questions